International dermatology outcome measures initiative as applied to psoriatic disease outcomes: An update

Joseph F. Merola; April W. Armstrong; Ami Saraiya; John Latella; Amit Garg; Kristina Callis Duffin; Alice B. Gottlieb

doi:10.3899/jrheum.160114

International dermatology outcome measures initiative as applied to psoriatic disease outcomes: An update

Joseph F. Merola, April W. Armstrong, Ami Saraiya, John Latella, Amit Garg, Kristina Callis Duffin, Alice B. Gottlieb

Research output: Contribution to journal › Short survey › peer-review

10 Scopus citations

Abstract

Previous publications have described the International Dermatology Outcome Measures (IDEOM) group, comprising patients, physicians, health economists, participating pharmaceutical industry partners, payers, and regulatory agencies. The goal of IDEOM is to create patient-centered, validated measures of dermatologic disease progression and treatment efficacy for use in both clinical trials and clinical practice. We provide an update of IDEOM activities as of our 2015 IDEOM meeting in Washington, DC, USA.

Original language	English
Pages (from-to)	959-960
Number of pages	2
Journal	Journal of Rheumatology
Volume	43
Issue number	5
DOIs	https://doi.org/10.3899/jrheum.160114
State	Published - May 2016
Externally published	Yes

Keywords

Ideom
Omeract
Outcome measures
Psoriasis

Access to Document

10.3899/jrheum.160114

Cite this

@article{455067550db74205b6aa56ae1e773407,

title = "International dermatology outcome measures initiative as applied to psoriatic disease outcomes: An update",

abstract = "Previous publications have described the International Dermatology Outcome Measures (IDEOM) group, comprising patients, physicians, health economists, participating pharmaceutical industry partners, payers, and regulatory agencies. The goal of IDEOM is to create patient-centered, validated measures of dermatologic disease progression and treatment efficacy for use in both clinical trials and clinical practice. We provide an update of IDEOM activities as of our 2015 IDEOM meeting in Washington, DC, USA.",

keywords = "Ideom, Omeract, Outcome measures, Psoriasis",

author = "Merola, {Joseph F.} and Armstrong, {April W.} and Ami Saraiya and John Latella and Amit Garg and Duffin, {Kristina Callis} and Gottlieb, {Alice B.}",

year = "2016",

month = may,

doi = "10.3899/jrheum.160114",

language = "English",

volume = "43",

pages = "959--960",

journal = "Journal of Rheumatology",

issn = "0315-162X",

publisher = "Journal of Rheumatology",

number = "5",

}

TY - JOUR

T1 - International dermatology outcome measures initiative as applied to psoriatic disease outcomes

T2 - An update

AU - Merola, Joseph F.

AU - Armstrong, April W.

AU - Saraiya, Ami

AU - Latella, John

AU - Garg, Amit

AU - Duffin, Kristina Callis

AU - Gottlieb, Alice B.

PY - 2016/5

Y1 - 2016/5

N2 - Previous publications have described the International Dermatology Outcome Measures (IDEOM) group, comprising patients, physicians, health economists, participating pharmaceutical industry partners, payers, and regulatory agencies. The goal of IDEOM is to create patient-centered, validated measures of dermatologic disease progression and treatment efficacy for use in both clinical trials and clinical practice. We provide an update of IDEOM activities as of our 2015 IDEOM meeting in Washington, DC, USA.

AB - Previous publications have described the International Dermatology Outcome Measures (IDEOM) group, comprising patients, physicians, health economists, participating pharmaceutical industry partners, payers, and regulatory agencies. The goal of IDEOM is to create patient-centered, validated measures of dermatologic disease progression and treatment efficacy for use in both clinical trials and clinical practice. We provide an update of IDEOM activities as of our 2015 IDEOM meeting in Washington, DC, USA.

KW - Ideom

KW - Omeract

KW - Outcome measures

KW - Psoriasis

UR - http://www.scopus.com/inward/record.url?scp=84969248254&partnerID=8YFLogxK

U2 - 10.3899/jrheum.160114

DO - 10.3899/jrheum.160114

M3 - Short survey

C2 - 27134269

AN - SCOPUS:84969248254

SN - 0315-162X

VL - 43

SP - 959

EP - 960

JO - Journal of Rheumatology

JF - Journal of Rheumatology

IS - 5

ER -

International dermatology outcome measures initiative as applied to psoriatic disease outcomes: An update

Abstract

Keywords

Access to Document

Fingerprint

Cite this